These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 8130181)
1. Acute elevation of endogenous prolactin does not influence glucose homeostasis in healthy men. Vigas M; Klimes I; Jurcovicová J; Jezová D Physiol Res; 1993; 42(5):341-5. PubMed ID: 8130181 [TBL] [Abstract][Full Text] [Related]
2. Effect of domperidone on the release of insulin after intravenous glucose load in man. Pezzarossa A; Vescovi PP; Cervigni C; Angelini O; Cimicchi MC; Capretti L; Campana G; Butturini U J Endocrinol Invest; 1986 Oct; 9(5):383-8. PubMed ID: 3540081 [TBL] [Abstract][Full Text] [Related]
3. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects. Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345 [TBL] [Abstract][Full Text] [Related]
4. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects. Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595 [TBL] [Abstract][Full Text] [Related]
5. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man. Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487 [TBL] [Abstract][Full Text] [Related]
6. Effects of pimozide and domperidone administration on prolactin levels in neonatally estrogenized female rats. Aguilar E; López F; Pinilla L; Bellido C; Vaticón MD Rev Esp Fisiol; 1985 Jun; 41(2):183-6. PubMed ID: 4041067 [TBL] [Abstract][Full Text] [Related]
7. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia. Webb CB; Thominet JL; Barowsky H; Berelowitz M; Frohman LA J Clin Endocrinol Metab; 1983 Jun; 56(6):1089-93. PubMed ID: 6841551 [TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women. Imrich R; Rovensky J; Cervenakova Z; Ksinantova L; Kvetnansky R; Koska J Int J Tissue React; 2002; 24(2):73-8. PubMed ID: 12182236 [TBL] [Abstract][Full Text] [Related]
9. Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Schernthaner G; Prager R; Punzengruber C; Luger A Diabetologia; 1985 Mar; 28(3):138-42. PubMed ID: 3888755 [TBL] [Abstract][Full Text] [Related]
10. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980 [TBL] [Abstract][Full Text] [Related]
11. Relation between luteinizing hormone and prolactin pulses in ovariectomized rats with or without dopamine inhibition. Pohl CR; Weiner RI; Smith MS Endocrinology; 1988 Sep; 123(3):1591-7. PubMed ID: 3402398 [TBL] [Abstract][Full Text] [Related]
12. [Kinetics of prolactinemia after withdrawal of dopamine perfusion and during the administration of domperidone. Normal and hyperprolactinemic subjects (prolactinomas and suprahypophyseal lesions)]. Bercovici JP; Khoury S; Tater D; Besson G; Caroff J Biomed Pharmacother; 1983; 37(5):222-7. PubMed ID: 6661508 [TBL] [Abstract][Full Text] [Related]